Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. GOOG
7. INTC
8. CSX
9. IBM
10. KNX

Go back to Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
(NASDAQ: VTRS) Delayed: 17.28 +0.27 (1.59%)
Previous Close $17.01    52 Week High $ 
Open $16.88    52 Week Low $ 
Day High $17.28    P/E N/A 
Day Low $16.76    EPS $ 
Volume 7,908,858